Needham & Company reiterates a 'Strong Buy' on Gilead Sciences Inc. (Nasdaq: GILD), price target $55.

Needham analyst says, "Nevertheless ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE